LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (4) , 507-513
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Comparison of Two LDL Cholesterol Targets after Ischemic StrokeNew England Journal of Medicine, 2020
- Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke SubtypesJAMA Neurology, 2020
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskEuropean Heart Journal, 2019
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trialThe Lancet, 2018
- Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial FibrillationThe American Journal of Cardiology, 2017
- Cholesterol-lowering interventions and stroke: Insights from IMPROVE-ITAtherosclerosis, 2016
- Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysisAtherosclerosis, 2016
- Atherothrombotic ischemic stroke in patients with atrial fibrillationClinical Neurology and Neurosurgery, 2007
- Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation StudiesCerebrovascular Diseases, 2000